Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
about
The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysisMicrosomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human diseaseLack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis.Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinomaHigh expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma.Maternal and offspring xenobiotic metabolism haplotypes and the risk of childhood acute lymphoblastic leukemiamEH Tyr113His polymorphism and the risk of ovarian cancer development.Genetic enhancement of microsomal epoxide hydrolase improves metabolic detoxification but impairs cerebral blood flow regulation.Try113His and His139Arg polymorphisms in the microsomal epoxide hydrolase gene are not associated with risk of breast cancer.CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study.N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia.Genetic variants associated with Fabry disease progression despite enzyme replacement therapy.Identification of ADH4 as a novel and potential prognostic marker in hepatocellular carcinoma.Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia.
P2860
Q28294622-53CC1D13-EFF5-4F90-BF39-6DC79743440CQ28608628-C85E3662-71F2-4703-B4C5-54DC54DC6410Q34364904-6FA963B5-8CEE-4D8A-9B7C-918EF862CC9AQ34602962-E6298BDF-41C4-4DE7-AA33-CCD2D567A4BBQ35440426-204A3532-EF4F-49A8-BF9D-2BFD1F3D625AQ36756043-567EAC69-0A64-445C-BF1F-84E5AA28A897Q36926478-DB4DE24F-42D1-47AF-8FD5-EDCA183D9147Q37408068-8EB01D01-E92F-42D4-B3BC-2B1D6F766CE8Q38397833-BD48AF9E-8D79-4722-A745-77C7B2926264Q38627269-911AB84F-5C0A-4336-A2AE-180884CCBBEEQ46522972-ABFDBD0E-ACD0-46A0-A044-09CF586BB15EQ47094778-3B987126-7CE5-403A-8975-FFAC4561986BQ53277915-4FD6ED9D-8DBD-45CE-BEBD-790E28E69763Q53280617-C483280A-6BDB-4677-AE59-0D5AD7EA9164
P2860
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
@ast
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
@en
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
@nl
type
label
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
@ast
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
@en
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
@nl
prefLabel
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
@ast
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
@en
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
@nl
P2093
P2860
P50
P356
P1476
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
@en
P2093
Andrew Berchuck
Brooke L Fridley
Catherine M Phelan
Ellen L Goode
Kristin L White
Melissa C Larson
Ovarian Cancer Association Consortium
Thomas A Sellers
Xiaoqing Chen
P2860
P304
P356
10.1002/MC.20714
P50
P577
2010-12-28T00:00:00Z